Page last updated: 2024-09-03

lestaurtinib and Leukemia, Promyelocytic, Acute

lestaurtinib has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burnett, AK; Gale, RE; Gilkes, AF; Grimwade, D; Hills, R; Kottaridis, PD; Linch, DC; Mills, KI; Nugent, E; Pizzey, AR; Solomon, E; Swirsky, D; Wheatley, K	1

Other Studies

1 other study(ies) available for lestaurtinib and Leukemia, Promyelocytic, Acute

Article	Year
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia. Blood, 2005, Dec-01, Volume: 106, Issue:12 Topics: Adolescent; Adult; Antineoplastic Agents; Carbazoles; Child; Child, Preschool; Female; fms-Like Tyrosine Kinase 3; Furans; Gene Expression Profiling; Humans; Indoles; Infant; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mutation; Oligonucleotide Array Sequence Analysis; Prognosis; Survival Analysis; Tretinoin	2005

Article

Year

Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.

Blood, 2005, Dec-01, Volume: 106, Issue:12

Topics: Adolescent; Adult; Antineoplastic Agents; Carbazoles; Child; Child, Preschool; Female; fms-Like Tyrosine Kinase 3; Furans; Gene Expression Profiling; Humans; Indoles; Infant; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mutation; Oligonucleotide Array Sequence Analysis; Prognosis; Survival Analysis; Tretinoin

2005